These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2390553)
1. Genetic screening for ethnic minorities. Modell M; Modell B BMJ; 1990 Jun; 300(6741):1702-4. PubMed ID: 2390553 [No Abstract] [Full Text] [Related]
2. Paediatrics among ethnic minorities. Afro-Caribbean and African families. Black J Br Med J (Clin Res Ed); 1985 Mar; 290(6473):984-8. PubMed ID: 3919879 [No Abstract] [Full Text] [Related]
3. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Mitchell JJ; Capua A; Clow C; Scriver CR Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593 [TBL] [Abstract][Full Text] [Related]
4. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938 [TBL] [Abstract][Full Text] [Related]
5. Sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency among Dhobis of Visakhapatnam, Andhra Pradesh, India. Ramesh M; Balakrishna A; Veerraju P Anthropol Anz; 1993 Jun; 51(2):173-7. PubMed ID: 8333737 [TBL] [Abstract][Full Text] [Related]
6. HIV and AIDS, other sexually transmitted diseases, and tuberculosis in ethnic minorities in United Kingdom: is surveillance serving its purpose? De Cock KM; Low N BMJ; 1997 Jun; 314(7096):1747-51. PubMed ID: 9202508 [TBL] [Abstract][Full Text] [Related]
7. Ethnic minorities and the Mental Health Act. Harrison G Br J Psychiatry; 2002 Mar; 180():198-9. PubMed ID: 11872509 [No Abstract] [Full Text] [Related]
8. Carrier parents of Tay Sachs disease and beta-thalassemia. Shah B; Bhavsar R Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705 [No Abstract] [Full Text] [Related]
9. Efficacy of a targeted genetic screening program for adolescents. McCabe L Am J Hum Genet; 1996 Oct; 59(4):762-3. PubMed ID: 8808589 [No Abstract] [Full Text] [Related]
10. Stigmatization of carrier status: social implications of heterozygote genetic screening programs. Kenen RH; Schmidt RM Am J Public Health; 1978 Nov; 68(11):1116-20. PubMed ID: 152585 [TBL] [Abstract][Full Text] [Related]
11. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. Modell B; Petrou M; Layton M; Varnavides L; Slater C; Ward RH; Rodeck C; Nicolaides K; Gibbons S; Fitches A; Old J BMJ; 1997 Sep; 315(7111):779-84. PubMed ID: 9345170 [TBL] [Abstract][Full Text] [Related]
12. International perspectives on the implementation of reproductive carrier screening. Delatycki MB; Alkuraya F; Archibald A; Castellani C; Cornel M; Grody WW; Henneman L; Ioannides AS; Kirk E; Laing N; Lucassen A; Massie J; Schuurmans J; Thong MK; van Langen I; Zlotogora J Prenat Diagn; 2020 Feb; 40(3):301-310. PubMed ID: 31774570 [TBL] [Abstract][Full Text] [Related]
13. Genetic screening for ethnic minorities. Bhavnani M BMJ; 1990 Aug 18-25; 301(6748):390. PubMed ID: 2400866 [No Abstract] [Full Text] [Related]
14. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia. Laberge AM; Watts C; Porter K; Burke W Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874 [TBL] [Abstract][Full Text] [Related]